2025
pubmed
Correction: Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis.
Tian. Qiru Q; Song. Yi Y; Deng. Yan Y; Lin. Shike S
Practical Outcomes
- There are no practical takeaways for biohackers; the correction does not change dosing, safety, or efficacy information.
Summary
The article is only a correction notice for a previous paper and does not provide any new data or guidance on tirzepatide use.
Abstract
[This corrects the article DOI: 10.3389/fendo.2025.1593134.].
Study Information
Provider
pubmed
Year
2025
Date
2025-08-25T00:00:00.000Z
DOI
10.3389/fendo.2025.1683829